Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05468008 · ClinicalTrials.gov registry record
Endoscopic Submucosal Dissection (ESD)
A clinical trial of Barrett Esophagus and Esophageal Lesion, sponsored by AdventHealth.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT05468008 is a study of Barrett Esophagus and Esophageal Lesion that is actively recruiting participants, run by AdventHealth. The registered enrollment target is 1,000 participants, below the 3,534-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05468008, a study of Barrett Esophagus and Esophageal Lesion, is actively recruiting participants, sponsored by AdventHealth.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic submucosal dissection. All patients will receive standard of medical care and no experimental interventions will be performed.
Conditions Studied
Interventions
- PROCEDURE Endoscopic Submucosal Dissection
Study Locations (1)
Florida
- AdventHealth Orlando - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2022-02-04 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05468008
The ClinicalTrials.gov registry entry for NCT05468008 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,534-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (72% lower). The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic Submucosal Dissection is the first listed.
NCT05468008 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05468008 about?
NCT05468008 is a clinical study titled "Endoscopic Submucosal Dissection (ESD)". This registry is to evaluate the procedural and clinical outcomes in patients undergoing endoscopic submucosal dissection. All patients will receive standard of medical care and no experimental interventions will be performed.
What is the current status of trial NCT05468008?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2022-02-04. Estimated completion is 2027-12.
What conditions does trial NCT05468008 study?
This clinical trial studies the following conditions: Barrett Esophagus, Esophageal Lesion, Gastrointestinal Lesions.
What interventions are being tested in trial NCT05468008?
The interventions under investigation include: Endoscopic Submucosal Dissection (PROCEDURE).
Who is sponsoring clinical trial NCT05468008?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05468008 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
-
Longitudinal Oral Microbiome Sampling for BE
RECRUITING
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.